First primary cancer site | Relatives with CRCa-2 | |||
---|---|---|---|---|
N a | RR b | 95%CI | ||
UAT | 10 | 2.05 | 1.10 | 3.80 |
Stomach | 6 | 1.50 | 0.67 | 3.35 |
Small intestine | < 5 | 0.81 | 0.11 | 5.75 |
Liver | < 5 | 0.59 | 0.08 | 4.21 |
Pancreas | < 5 | 0.87 | 0.12 | 6.19 |
Lung | < 5 | 1.21 | 0.45 | 3.22 |
Breast | 40 | 1.67 | 1.22 | 2.27 |
Cervix | 10 | 1.52 | 0.82 | 2.83 |
Endometrium | 15 | 1.46 | 0.88 | 2.41 |
Ovary | 8 | 1.54 | 0.77 | 3.08 |
Female genital | < 5 | 0.99 | 0.14 | 7.06 |
Prostate | 59 | 1.50 | 1.16 | 1.93 |
Testis | < 5 | 1.67 | 0.42 | 6.69 |
Male genital | < 5 | 3.51 | 0.88 | 14.02 |
Kidney | 10 | 2.36 | 1.27 | 4.39 |
Bladder | 15 | 1.25 | 0.76 | 2.08 |
Melanoma | 10 | 1.22 | 0.65 | 2.26 |
Skin | 13 | 1.20 | 0.70 | 2.07 |
Eye | < 5 | 2.33 | 0.58 | 9.32 |
Nervous system | 11 | 2.71 | 1.50 | 4.89 |
Thyroid | < 5 | 1.47 | 0.37 | 5.87 |
Endocrine gland | 8 | 1.72 | 0.86 | 3.43 |
Connective tissue | < 5 | 1.76 | 0.44 | 7.05 |
NHL | 6 | 1.13 | 0.51 | 2.53 |
Hodgkin lymphoma | < 5 | 3.01 | 0.75 | 12.03 |
Myeloma | < 5 | 1.84 | 0.69 | 4.90 |
Leukemia | < 5 | 0.87 | 0.28 | 2.70 |
CUP | < 5 | 1.43 | 0.36 | 5.72 |